IVD (in vitro diagnostic) labelling dilemma in central and eastern Europe
This article was originally published in Clinica
Language and labelling requirements in central and eastern European countries are causing problems for EU industry. But are they so different from the EU? Amanda Maxwell reports from Prague
You may also be interested in...
Revised bill released by the US Senate Finance Committee adjusts the manufacturer discount program in Medicare Part D and includes new provisions aimed at easing beneficiary cost sharing obligations.
Through a draft guidance, the US agency has established performance criteria for magnetic resonance coils, making the devices eligible for the standards-based Safety and Performance Based Pathway.
Singapore recalls trigger international reaction as metformin is added to growing list of chronic medications found to contain NDMA.